State Street Corp Nemaura Medical Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.71 - $2.86 $12,809 - $51,600	18,042 Added 50.65%	53,666 $48,000
Q1 2022 May 16, 2022	BUY	$3.78 - $4.66 $11,094 - $13,677	2,935 Added 8.98%	35,624 $156,000
Q4 2021 Feb 14, 2022	SELL	$4.12 - $6.35 $202,942 - $312,788	-49,258 Reduced 60.11%	32,689 $149,000
Q3 2021 Nov 15, 2021	SELL	$5.76 - $9.95 $116,593 - $201,407	-20,242 Reduced 19.81%	81,947 $493,000
Q2 2021 Aug 16, 2021	SELL	$4.7 - $16.7 $17,822 - $63,326	-3,792 Reduced 3.58%	102,189 $1.06 Million
Q1 2021 May 17, 2021	BUY	$3.79 - $9.78 $157,664 - $406,848	41,600 Added 64.62%	105,981 $810,000
Q4 2020 Feb 16, 2021	SELL	$3.47 - $4.52 $8,675 - $11,299	-2,500 Reduced 3.74%	64,381 $243,000
Q3 2020 Nov 10, 2020	SELL	$3.55 - $9.99 $3,805 - $10,709	-1,072 Reduced 1.58%	66,881 $237,000
Q2 2020 Aug 14, 2020	BUY	$4.75 - $15.38 $322,776 - $1.05 Million	67,953 New	67,953 $629,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.